By demonstrating that Type B HCC-CC has a gene expression similar to iCCA while the Type C HCC-CC genetic signature resembles HCC, the hypothesis of different treatments according to histotype gained support. The gene discussed is PRRT2; the disease is hepatocellular carcinoma.